Edition:
United States

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

30,332.00ZAc
20 Sep 2017
Change (% chg)

-144.00 (-0.47%)
Prev Close
30,476.00
Open
30,400.00
Day's High
30,684.00
Day's Low
30,257.00
Volume
1,004,559
Avg. Vol
1,152,922
52-wk High
32,880.00
52-wk Low
25,564.00

Latest Key Developments (Source: Significant Developments)

Aspen Pharmacare Holdings posts FY revenue 41,2 bln rand
Thursday, 14 Sep 2017 02:00am EDT 

Sept 14 (Reuters) - ASPEN PHARMACARE HOLDINGS LTD :FY REVENUE BY 16% TO 41,2 BILLION RAND.RAISED NORMALISED HEADLINE EARNINGS PER SHARE ("NHEPS") BY 16% TO 1 463 CENTS IN YEAR ENDED 30 JUNE 2017..HAS DECLARED A GROSS DIVIDEND, WHICH IS PAID FROM INCOME RESERVES, OF 287 CENTS PER ORDINARY SHARE TO SHAREHOLDERS.  Full Article

Aspen Pharmacare sees full-year NHEPS up 13 pct-18 pct
Wednesday, 30 Aug 2017 08:00am EDT 

Aug 30 (Reuters) - Aspen Pharmacare Holdings Ltd ::‍SEES FY NEHPS AT 1428.0 CENTS PER SHARE TO 1491.2 CENTS PER SHARE, UP 13 PERCENT - 18 PERCENT.SEES HEPS UP 43 PCT TO 48 PCT TO 1271.3 CENTS PER SHARE TO 1315.7 CENTS PER SHARE IN YEAR TO JUNE 30, 2017​​.‍SIGNIFICANT INCREASE IN HEADLINE EARNINGS PER SHARE IS ATTRIBUTABLE TO DEVALUATION OF ASPEN'S VENEZUELAN BUSINESS IN PRIOR YEAR​.  Full Article

Aspen Pharmacare says Italian court directs co to pay fine of 5.2 mln euros
Wednesday, 14 Jun 2017 10:00am EDT 

June 14 (Reuters) - Aspen Pharmacare Holdings Ltd ::Has been informed that Italian court has dismissed Aspen's appeal against Italian Competition Authority.Appeal relating to Aspen's portfolio of oncology products distributed in Italy.Effect of ruling is that Aspen will be obliged to now pay fine imposed by ICA in amount of eur 5.2 million, plus interest thereon.Says will engage its advisers and consider matter further against receipt of those reasons.  Full Article

Aspen Pharmacare says not yet had any engagement with commission on matters raised
Wednesday, 14 Jun 2017 05:11am EDT 

June 14 (Reuters) - Aspen Pharmacare Holdings Ltd :‍To date, not had any engagement with commission on matters contained in commission's announcement of 13 June 2017​.  Full Article

Aspen Pharmacare responds to South African Competition Commission investigation announcement
Tuesday, 13 Jun 2017 09:00am EDT 

June 13 (Reuters) - Aspen Pharmacare Holdings Ltd :Noted announcement by South African Competition Commission.Announcement that SACC will be investigating co for suspected abuse of dominance in respect of provision of cancer medication in South Africa.‍Committed to full and constructive engagement with Competition Commission in this investigation.Not increased pricing of its products outside of this regulatory framework.Clearly demonstrated its commitment to providing quality medicines affordably over many years; Supply of oncology products in question is no exception​​​​.  Full Article

Aspen Pharmacare says hasn't raised prices outside regulatory framework
Tuesday, 30 May 2017 02:45am EDT 

May 30 (Reuters) - Aspen Pharmacare Holdings Ltd ::Further confirms pharmaceutical prices are approved by department of health in terms of single exit price regulatory framework.Aspen had not increased pricing of its products outside of this regulatory framework."Democratic Alliance is satisfied that there is no evidence that Aspen is involved in same practices that they are accused of having pursued in Europe​".  Full Article

Aspen says EC to investigate co, European units
Monday, 15 May 2017 06:10am EDT 

May 15 (Reuters) - Aspen Pharmacare Holdings Ltd ::Opening of European Commission proceedings.Confirms European Commission opened proceedings to investigate certain actions of Aspen Holdings, certain of its European subsidiaries.Will work constructively with European Commission in its process.Not currently in a position to comment on these proceedings.  Full Article

Aspen says welcome probe into allegations of anti-competitive behavior
Monday, 24 Apr 2017 02:00am EDT 

April 24 (Reuters) - Aspen ::Notes media reports that competition commission has decided to take up democratic alliance's request to investigate alleged anti-competitive conduct of co in South Africa.Welcomes process and opportunity to categorically set aside such allegations of anti- competitive behavior.Committed to full and constructive engagement with competition commission should it wish to pursue such an investigation.Aspen has not increased pricing of its products outside of this regulatory framework.  Full Article

Aspen to not comment on allegations in press reports
Tuesday, 18 Apr 2017 02:00am EDT 

April 18 (Reuters) - Aspen Pharmacare Holdings Limited ::Aspen’S response to the press reports of 14 and 15 April 2017.Demonstrated commitment to providing medicines affordably over many years, supply of oncology products in question is no exception.Aspen will not comment on these public allegations.Aspen looks forward to opportunity to demonstrate integrity and legality of its practices in context of these legal processes..Oncology portfolio in question generated revenue in EU in Aspen's FY ended 30 June 2016 of EUR 60 million (963 mln rand).  Full Article

Aspen Pharmacare says HY normalised HEPS rose 6 pct to 692 cents
Thursday, 9 Mar 2017 12:30am EST 

Aspen Pharmacare Holdings Ltd : HY revenue for group grew 13% to R19,8 billion and normalised headline earnings per share increased by 6% to 692 cents . Results in second half of 2017 financial year will be influenced by strengthening of rand .Says overall stronger underlying performance in second half of 2017 financial year is anticipated.  Full Article

UPDATE 2-Aspen Pharmacare shifts the needle to injectibles

JOHANNESBURG, Sept 14 South Africa's Aspen Pharmacare expanded its anaesthetic drugs portfolio with a $766 million deal with AstraZeneca as it focuses on injectibles rather than making tablets.